Scandinavian Biopharma Distribution ApS: Financial statements 2025
CVR: 44809028
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Scandinavian Biopharma Distribution ApS (CVR 44809028) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 465,504 and a net result of DKK -598,173. Equity in the 2025 report amounted to DKK -536,459. The company had 1 employee in the financial year.
- Gross Profit
- DKK 465,504
- Profit/Loss
- DKK -598,173
- Equity
- DKK -536,459
- Total Assets
- DKK 2,704,976
- Employees
- 1
Official annual report
How creditworthy is Scandinavian Biopharma Distribution ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Scandinavian Biopharma Distribution ApS has published its interim report for the period May 1, 2024 to December 31, 2024.
About Scandinavian Biopharma Distribution ApS
Scandinavian Biopharma Distribution ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2024. The company is registered under the industry Ikke-specialiseret engroshandel med føde-, drikke- og tobaksvarer. The company was previously named ApS KBUS 18 nr. 750. The management consists of Björn Magnus Sjöstrand and Pehr Jonas Bengtsson. The company is owned by Scandinavian Biopharma Distribution AB. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 465,504 and a net result of DKK -598,173. Equity in the 2025 report amounted to DKK -536,459.
